Showing results (1631-1640 of 3,474) with videos related to

Sort By:
Pageof 348
Clinical Pharmacokinetics|December 3, 2024
Population Pharmacokinetic and Toxicity Analysis of High-Dose Methotrexate in Patients with Central Nervous System LymphomaAnyue Yin, Fleur A de Groot, Henk-Jan Guchelaar, et al.
Clinical Pharmacokinetics|October 28, 2024
Population Pharmacokinetic Modelling of Norepinephrine in Healthy Volunteers Prior to and During General AnesthesiaYingxue Li, Jeroen V Koomen, Douglas J Eleveld, et al.
Clinical Pharmacokinetics|October 22, 2024
A Sequential Population Pharmacokinetic Model of Zilovertamab Vedotin in Patients with Hematologic Malignancies Extrapolated to the Pediatric PopulationThijs J Zweers, Jos Lommerse, Eline van Maanen, et al.
Clinical Pharmacokinetics|October 16, 2024
Assessing Human Iron Kinetics Using Stable Iron Isotopic TechniquesNicole U Stoffel, Christophe Zeder, Michael B Zimmermann
Clinical Pharmacokinetics|September 7, 2024
Dose Justification for Asciminib in Patients with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia with and Without the T315I MutationFrancois Pierre Combes, Sherwin K B Sy, Ying Fei Li, et al.
Clinical Pharmacokinetics|August 22, 2024
Population Pharmacokinetics and Pharmacodynamics of Dalbavancin and C-Reactive Protein in Patients with Staphylococcal Osteoarticular InfectionsPier Giorgio Cojutti, Sara Tedeschi, Eleonora Zamparini, et al.
Clinical Pharmacokinetics|July 16, 2024
Clinical Pharmacokinetics and Pharmacodynamics of Letermovir in Allogenic Hematopoietic Cell TransplantationKimitaka Suetsugu, Tomohiro Shigematsu, Takahiro Nakamura, et al.
Clinical Pharmacokinetics|July 31, 2024
A Machine Learning Algorithm to Predict the Starting Dose of DaptomycinFlorence Rivals, Sylvain Goutelle, Cyrielle Codde, et al.
Clinical Pharmacokinetics|July 2, 2024
Penetration of Antibiotics into Subcutaneous and Intramuscular Interstitial Fluid: A Meta-Analysis of Microdialysis Studies in AdultsPieter-Jan De Sutter, Eline Hermans, Pieter De Cock, et al.
Clinical Pharmacokinetics|July 4, 2024
Intra-individual Dose Escalation of Abiraterone According to Its Plasma Exposure in Patients with Progressive Metastatic Castration-Resistant Prostate Cancer: Results of the OPTIMABI TrialJérôme Alexandre, Stephane Oudard, Lisa Golmard, et al.
Pageof 348